DeepMed Research

Nanfang Hospital Southern Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

E-aid Cognitive Behavior Therapy for Insomnia to Prevent Transition From Acute Insomnia to Chronic Insomnia in China

Not Applicable

Completed

Conditions: Insomnia

Interventions: Behavioral: eCBTI

First Posted Date: 2017-10-05

Last Posted Date: 2020-10-20

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 192

Registration Number: NCT03302455

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)

Conditions: Alcoholic Liver Disease

First Posted Date: 2017-09-28

Last Posted Date: 2018-01-23

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 3000

Registration Number: NCT03295812

Locations: 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China
🇨🇳
Dongguan dalang hospital, Dongguan, China
🇨🇳
People's hospital of Foshan Nanhai District, Foshan, China

and more 23 locations

Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma

Conditions: Liver Failure
Hepatocellular Carcinoma

Interventions: Procedure: TACE

First Posted Date: 2017-09-18

Last Posted Date: 2018-04-30

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 200

Registration Number: NCT03285867

Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism

Phase 2

Completed

Conditions: Acute Stroke

Interventions: Drug: Placebo
Drug: Glibenclamide

First Posted Date: 2017-09-15

Last Posted Date: 2023-06-12

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 306

Registration Number: NCT03284463

Locations: 🇨🇳
Huadu District People's Hospital of Guangzhou, Guangzhou, Guangdong, China
🇨🇳
Maoming People's Hospital, Maoming, Guangdong, China
🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

and more 5 locations

A Prospective Study of Evaluation of Minor Bleeding and Utility of Bleeding Criteria in Acute-on-chronic Liver Failure Patients in China

Conditions: Liver Failure, Acute on Chronic
Hemostatic Disorder

First Posted Date: 2017-09-13

Last Posted Date: 2017-09-13

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 100

Registration Number: NCT03281252

Locations: 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China

A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China

Completed

Conditions: Liver Injury
Liver Failure, Acute on Chronic

First Posted Date: 2017-09-13

Last Posted Date: 2018-01-23

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 1178

Registration Number: NCT03281265

A Prospective Study of Application of Platelet Mapping in HBV-related Acute-on-chronic-liver Failure in China

Completed

Conditions: Thrombelastography,Acute on Chronic Liver Failure, Platelet

First Posted Date: 2017-09-13

Last Posted Date: 2019-06-06

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 100

Registration Number: NCT03281278

Locations: 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China

Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified

Phase 1

Conditions: Beta Thalassemia Major

Interventions: Genetic: Autologous CD34+ cells genetically modified

First Posted Date: 2017-09-08

Last Posted Date: 2017-09-08

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 10

Registration Number: NCT03276455

Locations: 🇨🇳
Nanfang Hospial, Guangzhou, Guangdong, China

Lactate Clearance Goal-directed Therapy in Sepsis

Not Applicable

Conditions: Sepsis

Interventions: Behavioral: Lactate clearance 20% target group
Behavioral: Lactate clearance 10% target group
Behavioral: Standard EGDT group

First Posted Date: 2017-08-22

Last Posted Date: 2017-08-22

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 1128

Registration Number: NCT03256461

Locations: 🇨🇳
NanFang hospital, Guangzhou, Guangdong, China

BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT

Phase 2

Conditions: Diffuse Large B-cell Lymphoma
Autologous Hematopoietic Stem Cell Transplantation
Conditioning

Interventions: Drug: Busulfan (BU)
Drug: Cyclophosphamide (CY)
Drug: Etoposide (VP-16)

First Posted Date: 2017-07-25

Last Posted Date: 2017-10-12

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 122

Registration Number: NCT03229616

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy